MITHRA PHARMACEUTICALS SA financial statements, including revenue, expenses, profit, and loss
The total revenue of MITPF for the last semiannual is 36.56 M USD, and it's 376.40% higher compared to the previous semiannual. The net income of H2 23 is -135.80 M USD.